Literature DB >> 33419024

Validation of Clinical Characteristics and Effectiveness of Pulmonary Rehabilitation in a COPD Population with Discrepancy between Exercise Tolerance and FEV1.

Jun Horie1, Koichiro Takahashi2, Shuuichi Shiranita3, Kunihiko Anami4, Shinichiro Hayashi5.   

Abstract

This study's objective was to examine the characteristics of patients with chronic obstructive pulmonary disease (COPD) presenting with various exercise tolerance levels. A total of 235 patients with stable COPD were classified into 4 groups: (1) LoFlo + HiEx-patients with a six-minute walking distance (6MWD) ≥350 m and percentage of predicted forced expiratory volume in 1 s (%FEV1.0) <50%; (2) HiFlo + HiEx-patients with a 6MWD ≥350 m and a %FEV1.0 ≥50%; (3) LoFlo + LoEx-patients with a 6MWD < 350 m and %FEV1.0 < 50%; and (4) HiFlo + LoEx-patients with a 6MWD <350 m and %FEV1.0 ≥ 50%. Aspects of physical ability in the HiFlo + LoEx group were significantly lower than those in the HiFlo + HiEx group. The HiFlo + LoEx group was characterized by a history of hospitalization for respiratory illness within the past year, treatment with at-home oxygen therapy, and lacking daily exercise habits. Following three months of pulmonary rehabilitation, the LoFlo + HiEx group significantly improved in the modified Medical Research Council dyspnea score, maximum gait speed, and 6MWD, while the HiFlo + LoEx group significantly improved in the percentage of maximal expiratory pressure, maximum gait speed, 6MWD, incremental shuttle walking distance, and St. George's Respiratory Questionnaire score. The HiFlo + LoEx group had the greatest effect of three-month pulmonary rehabilitation compared to other groups.

Entities:  

Keywords:  COPD management; chronic obstructive pulmonary disease; exercise tolerance; forced expiratory volume; rehabilitation

Year:  2021        PMID: 33419024      PMCID: PMC7825294          DOI: 10.3390/healthcare9010053

Source DB:  PubMed          Journal:  Healthcare (Basel)        ISSN: 2227-9032


  27 in total

1.  Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort.

Authors:  Martijn A Spruit; Michael L Watkins; Lisa D Edwards; Jørgen Vestbo; Peter M A Calverley; Victor Pinto-Plata; Bartolome R Celli; Ruth Tal-Singer; Emiel F M Wouters
Journal:  Respir Med       Date:  2010-05-14       Impact factor: 3.415

2.  Health status deterioration in patients with chronic obstructive pulmonary disease.

Authors:  S Spencer; P M Calverley; P Sherwood Burge; P W Jones
Journal:  Am J Respir Crit Care Med       Date:  2001-01       Impact factor: 21.405

3.  Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease.

Authors:  D E O'Donnell; S M Revill; K A Webb
Journal:  Am J Respir Crit Care Med       Date:  2001-09-01       Impact factor: 21.405

Review 4.  Pulmonary rehabilitation for chronic obstructive pulmonary disease.

Authors:  Bernard McCarthy; Dympna Casey; Declan Devane; Kathy Murphy; Edel Murphy; Yves Lacasse
Journal:  Cochrane Database Syst Rev       Date:  2015-02-23

5.  Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease.

Authors:  Anne E Holland; Catherine J Hill; Tshepo Rasekaba; Annemarie Lee; Matthew T Naughton; Christine F McDonald
Journal:  Arch Phys Med Rehabil       Date:  2010-02       Impact factor: 3.966

6.  Is a pulmonary rehabilitation program effective in COPD patients with chronic hypercapnic failure?

Authors:  Hulya Sahin; Ilknur Naz; Yelda Varol; Nimet Aksel; Fevziye Tuksavul; Ayse Ozsoz
Journal:  Expert Rev Respir Med       Date:  2016-03-28       Impact factor: 3.772

7.  Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status.

Authors:  Toru Oga; Koichi Nishimura; Mitsuhiro Tsukino; Susumu Sato; Takashi Hajiro
Journal:  Am J Respir Crit Care Med       Date:  2002-11-21       Impact factor: 21.405

8.  Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease.

Authors:  R Casaburi; A Patessio; F Ioli; S Zanaboni; C F Donner; K Wasserman
Journal:  Am Rev Respir Dis       Date:  1991-01

9.  Characterisation of COPD heterogeneity in the ECLIPSE cohort.

Authors:  Alvar Agusti; Peter M A Calverley; Bartolome Celli; Harvey O Coxson; Lisa D Edwards; David A Lomas; William MacNee; Bruce E Miller; Steve Rennard; Edwin K Silverman; Ruth Tal-Singer; Emiel Wouters; Julie C Yates; Jørgen Vestbo
Journal:  Respir Res       Date:  2010-09-10

10.  The prevalence of quadriceps weakness in COPD and the relationship with disease severity.

Authors:  J M Seymour; M A Spruit; N S Hopkinson; S A Natanek; W D-C Man; A Jackson; H R Gosker; A M W J Schols; J Moxham; M I Polkey; E F M Wouters
Journal:  Eur Respir J       Date:  2009-11-06       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.